These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6783946

  • 21. Effects of buprenorphine, a new narcotic agonist-antagonist analgesic on the EEG, power spectrum and behavior of the rat.
    Kareti S, Moreton JE, Khazan N.
    Neuropharmacology; 1980 Feb; 19(2):195-201. PubMed ID: 7360334
    [No Abstract] [Full Text] [Related]

  • 22. Effects of buprenorphine on candy and sweetened fluid self-administration by rhesus monkeys.
    Comer SD, Evans SM, Pudiak CM, Foltin RW.
    Psychopharmacology (Berl); 2002 Nov; 164(2):200-6. PubMed ID: 12404083
    [Abstract] [Full Text] [Related]

  • 23. Interaction of combined administration of intrathecal morphine with subcutaneous morphine or buprenorphine.
    Chen LH, Nemirovsky A, Gong QY.
    Acta Pharmacol Sin; 2000 Aug; 21(8):685-9. PubMed ID: 11501175
    [Abstract] [Full Text] [Related]

  • 24. Clinical analgesic assay of sublingual buprenorphine and intramuscular morphine.
    Wallenstein SL, Kaiko RF, Rogers AG, Houde RW.
    NIDA Res Monogr; 1982 Apr; 41():288-93. PubMed ID: 6811921
    [Abstract] [Full Text] [Related]

  • 25. Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure.
    Walker EA, Zernig G, Woods JH.
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1345-52. PubMed ID: 7791107
    [Abstract] [Full Text] [Related]

  • 26. [Effect of agonistic morphine antagonists (cyclazocine, butorphanol, buprenorphine) on EEG activity and the depth of anesthesia in rats].
    Ogawa T, Sano Y, Hirabayshi Y, Yoshikawa H, Wauquier A, Cuesta P, Clinken B, William M, Van den Broeck.
    Masui; 1987 Apr; 36(4):490-7. PubMed ID: 3613060
    [No Abstract] [Full Text] [Related]

  • 27. The animal pharmacology of buprenorphine, an oripavine analgesic agent.
    Cowan A, Doxey JC, Harry EJ.
    Br J Pharmacol; 1977 Aug; 60(4):547-54. PubMed ID: 409449
    [Abstract] [Full Text] [Related]

  • 28. Haemodynamic changes following buprenorphine and morphine.
    Scott DH, Arthur GR, Scott DB.
    Anaesthesia; 1980 Oct; 35(10):957-61. PubMed ID: 7004250
    [Abstract] [Full Text] [Related]

  • 29. Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone.
    Sell SL, McMahon LR, France CP.
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1167-73. PubMed ID: 12766254
    [Abstract] [Full Text] [Related]

  • 30. [Sequential anesthesia-analgesia: sulfentanyl-buprenorphine combination].
    Arroyo Carreras JL, Medina Enríquez J, Carrascosa Moreno F, Pérez Reiner R, Pezonaga Pĕrez L, González Esparza L, El Busto Osacar JJ.
    Rev Esp Anestesiol Reanim; 1978 Mar; 25(2):149-57. PubMed ID: 694147
    [No Abstract] [Full Text] [Related]

  • 31. Effects of intravenous morphine and buprenorphine on a C-fiber reflex in the rat.
    Guirimand F, Chauvin M, Willer JC, Le Bars D.
    J Pharmacol Exp Ther; 1995 May; 273(2):830-41. PubMed ID: 7752087
    [Abstract] [Full Text] [Related]

  • 32. Secondary reinforcing effects of opiate agonists in mice.
    Zvartu EE, Kovalenko VS.
    Neurosci Behav Physiol; 1987 May; 17(5):379-86. PubMed ID: 2829054
    [No Abstract] [Full Text] [Related]

  • 33. Differential tolerance development to buprenorphine-, diprenorphine-, and heroin-induced disruption of food-maintained responding in macaque monkeys.
    Lukas SE, Mello NK, Bree MP, Mendelson JH.
    Pharmacol Biochem Behav; 1988 Aug; 30(4):977-82. PubMed ID: 3227044
    [Abstract] [Full Text] [Related]

  • 34. [Method for evaluating the reinforcing properties of morphine in a model of addictive behavior].
    Surkova LA, Tiurina IV.
    Farmakol Toksikol; 1989 Aug; 52(4):93-5. PubMed ID: 2806539
    [Abstract] [Full Text] [Related]

  • 35. [Our experience with a long-acting analgesic: buprenorphine].
    Lo Mele FP, De Meo M, Caroprese VL, Di Biase R, Memoli G.
    Minerva Anestesiol; 1984 Apr; 50(4):133-6. PubMed ID: 6472645
    [No Abstract] [Full Text] [Related]

  • 36. [Buprenorphine (author's transl)].
    Yamamura H.
    Masui; 1981 Oct; 30(10):1029-33. PubMed ID: 7328727
    [No Abstract] [Full Text] [Related]

  • 37. Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys.
    Beardsley PM, Aceto MD, Cook CD, Bowman ER, Newman JL, Harris LS.
    Exp Clin Psychopharmacol; 2004 Aug; 12(3):163-72. PubMed ID: 15301633
    [Abstract] [Full Text] [Related]

  • 38. Buprenorphine self-administration by the baboon: comparison with other opioids.
    Lukas SE, Griffiths RR, Brady JV.
    NIDA Res Monogr; 1983 Apr; 43():178-83. PubMed ID: 6410250
    [No Abstract] [Full Text] [Related]

  • 39. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice.
    Jardinaud F, Roques BP, Noble F.
    Behav Brain Res; 2006 Oct 16; 173(2):255-61. PubMed ID: 16884789
    [Abstract] [Full Text] [Related]

  • 40. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
    Fischer BD, Dykstra LA.
    J Pharmacol Exp Ther; 2006 Sep 16; 318(3):1300-6. PubMed ID: 16772537
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.